Relmada Therapeutics (RLMD) Notes Payables (2014 - 2019)
Relmada Therapeutics (RLMD) posted quarterly Notes Payables of $110247.0 for Q4 2019, down 3.91% year-over-year from $114738.0 in Q4 2018, and down 56.92% quarter-over-quarter from $255925.0 in Q3 2019.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Notes Payables (2014 - 2019) Analysis & Trends
Relmada Therapeutics (RLMD) has reported Notes Payables for 6 consecutive years, with $110247.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Notes Payables fell 3.91% year-over-year to $110247.0; the TTM figure through Dec 2019 stood at $110247.0 (down 3.91% YoY), while the FY2019 annual figure was $110247.0, changed N/A from the prior year.
- Notes Payables eased to $110247.0 in Q4 2019 per RLMD's latest filing, from $255925.0 in the prior quarter.
- Across five years, Notes Payables topped out at $24.5 million in Q1 2015 and bottomed at $27880.0 in Q1 2018.
- Historically, Notes Payables has averaged $2.6 million across 5 years, with a median of $282300.0 in 2017.
- On a YoY basis, Notes Payables climbed as much as 23892.61% in 2015 and fell as far as 99.67% in 2015.
- Relmada Therapeutics' Notes Payables stood at $88533.0 in 2015, then soared by 491.31% to $523505.0 in 2016, then surged by 603.62% to $3.7 million in 2017, then plunged by 96.89% to $114738.0 in 2018, then declined by 3.91% to $110247.0 in 2019.
- Business Quant data shows RLMD's Notes Payables at $110247.0 in Q4 2019, $255925.0 in Q3 2019, and $364204.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Relmada Therapeutics | 498.39 Mn | 498.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 110,247.00 |
| Sep 30, 2019 | 255,925.00 |
| Jun 30, 2019 | 364,204.00 |
| Mar 31, 2019 | 28,769.00 |
| Dec 31, 2018 | 114,738.00 |
| Sep 30, 2018 | 4.51 Mn |
| Jun 30, 2018 | 4.19 Mn |
| Mar 31, 2018 | 3.96 Mn |
| Dec 31, 2017 | 3.68 Mn |
| Sep 30, 2017 | 2.52 Mn |
| Jun 30, 2017 | 276,670.00 |
| Mar 31, 2017 | 279,430.00 |
| Dec 31, 2016 | 523,505.00 |
| Sep 30, 2016 | 972,546.00 |
| Jun 30, 2016 | 892,503.00 |
| Mar 31, 2016 | 614,079.00 |
| Dec 31, 2015 | 1.45 Mn |
| Sep 30, 2015 | 4.71 Mn |
| Jun 30, 2015 | 14.00 Mn |
| Mar 31, 2015 | 24.47 Mn |